Created at 3:12 a.m. Apr, 02, 2026
Bulk Suggestion
Bulk ID:
drradiology/04.02.26-03:12AM
Author:
drradiology
Type of change:
Updated content
Rationale for change
Minor updates
Current
Suggested
Text
Text
Text
Text
Hint Image
Empty field
Note ID
bd0cc7a0-2559-11f1-b70c-00410e25b0ac
Extra
“5 for 5 keeps the liver alive"
Technically it’s 2.5 mg/kg twice a day - but that doesn’t rhyme.
On HIDA in infants, visualization of tracer in the bowel confirms patency (e.g., hepatitis), although delayed imaging up to 24 hours may be required.
Absence of bowel activity does not confirm biliary atresia unless the study is performed after phenobarbital pretreatment.
Phenobarbital is used to stimulate hepatocyte function by upregulating bilirubin conjugation and excretion, improving test accuracy.
Standard protocol includes phenobarbital pretreatment for several days prior to HIDA to reduce false positives for biliary atresia.
Core exam pearl: No bowel activity after phenobarbital pretreatment strongly suggests biliary atresia.
Technically it’s 2.5 mg/kg twice a day - but that doesn’t rhyme.
On HIDA in infants, visualization of tracer in the bowel confirms patency (e.g., hepatitis), although delayed imaging up to 24 hours may be required.
Absence of bowel activity does not confirm biliary atresia unless the study is performed after phenobarbital pretreatment.
Phenobarbital is used to stimulate hepatocyte function by upregulating bilirubin conjugation and excretion, improving test accuracy.
Standard protocol includes phenobarbital pretreatment for several days prior to HIDA to reduce false positives for biliary atresia.
Core exam pearl: No bowel activity after phenobarbital pretreatment strongly suggests biliary atresia.
Extra Image
Empty field
Personal Notes
Empty field
Core Radiology
Empty field
Radiopaedia Images
Empty field
Radiopaedia Text
Empty field
Additional Resources
Empty field
Case_File_ID
Empty field
TTS Audio
Empty field
TTS Audio Front
[sound:05a4542c492c79adb461af39a9b61eda.mp3]
TTS Audio Extra
Empty field